Features
Associate Salary Stratification More Likely In 'Buyer's Market'
Since Cravath, Swaine & Moore upped the ante on associate salaries this Spring, others in the big law community have responded gradually, some going all-in and others devising region-specific pay scales. In the current market, industry watchers say, the salary game has changed, and most firms will need to take the more thoughtful approach.
Features
Firms Increasingly Making Partners Pay to Leave
As law firms look to protect themselves from cash walking out the door in a low-demand market, they are increasingly looking at methods to discourage lateral departures and, perhaps more importantly, are enforcing those methods more frequently.
Columns & Departments
In the Courts
Discussion of a case in which the Supreme Court vacated the conviction of ex-Virginia Governor Bob McDonnell.
EFF Challenges DMCA's Anti-Circumvention Provision
The Electronic Frontier Foundation and Wilson Sonsini Goodrich & Rosati have teamed up to challenge provisions in U.S. copyright law that threaten harsh penalties for breaking "digital locks" guarding content such as music and software code.
Features
Recent Guidance Regarding Deduction of Fines
Internal Revenue Code ' 162 provides: "No deduction shall be allowed under subsection (a) for any fine or similar penalty paid to a government for the violation of any law." The controversies that continue to arise under ' 162(f) are illustrated by two memoranda released within the past few months.
Features
The Adjudication of Affordability
Since the first civil lawsuit for money damages, plaintiffs have sought to maximize recoveries while defendants have sought to minimize them. This creates an obvious tension that is often left to a jury. Now, we have a new wrinkle in the issue, courtesy of the Affordable Care Act (ACA). How will it affect the award of money damages in civil lawsuits?
Columns & Departments
<b><i>Legal Tech:</b></i> Modernizing Litigation Practice: What Can the U.S. Learn from Electronic Courtrooms and Paperless Trials Abroad?
Legal professionals interested in the next wave of innovation in litigation technology can look overseas to the developments over the last several years in the UK and Singapore.
Features
Investing in New Technologies
Until recently, corporate legal departments often had more leeway in complying with corporate operational and budgetary expectations than other departments. Now, however, companies are expecting legal departments to more accurately predict the quality, timing and cost for their services.
Companies Slow to Respond to New Accounting Standards
A recent survey by audit, tax and advisory firm KPMG LLP indicates that nearly 80% of public companies have not completed an assessment of the impacts of the new revenue recognition standard issued by the Financial Accounting Standards Board (FASB).
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Protecting Innovation in the Cyber World from Patent TrollsWith trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.Read More ›
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›